AU2003225705A1 - Cytidine analogs and methods of use - Google Patents
Cytidine analogs and methods of useInfo
- Publication number
- AU2003225705A1 AU2003225705A1 AU2003225705A AU2003225705A AU2003225705A1 AU 2003225705 A1 AU2003225705 A1 AU 2003225705A1 AU 2003225705 A AU2003225705 A AU 2003225705A AU 2003225705 A AU2003225705 A AU 2003225705A AU 2003225705 A1 AU2003225705 A1 AU 2003225705A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- cytidine analogs
- cytidine
- analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/006992 WO2004080466A1 (en) | 2003-03-07 | 2003-03-07 | Cytidine analogs and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003225705A1 true AU2003225705A1 (en) | 2004-09-30 |
Family
ID=32986323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003225705A Abandoned AU2003225705A1 (en) | 2003-03-07 | 2003-03-07 | Cytidine analogs and methods of use |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003225705A1 (en) |
| WO (1) | WO2004080466A1 (en) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| CZ301182B6 (en) | 2000-05-26 | 2009-12-02 | Idenix (Cayman) Limited | Use of nucleoside derivatives for preparation of pharmaceutical compositions for treating infections caused by flaviviruses and pestiviruses |
| CN101172993A (en) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| WO2004002422A2 (en) | 2002-06-28 | 2004-01-08 | Idenix (Cayman) Limited | 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| ES2624353T3 (en) | 2002-11-15 | 2017-07-13 | Idenix Pharmaceuticals Llc | 2'-Methyl nucleosides in combination with interferon and Flaviviridae mutation |
| RU2005121904A (en) | 2002-12-12 | 2006-01-20 | Айденикс (Кайман) Лимитед (Ky) | METHOD FOR PRODUCING 2`-BRANCHED NUCLEOSIDES |
| EP4032897B1 (en) | 2003-05-30 | 2025-01-29 | Gilead Pharmasset LLC | Modified fluorinated nucleoside analogues |
| CN101023094B (en) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| WO2006031725A2 (en) | 2004-09-14 | 2006-03-23 | Pharmasset, Inc. | Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| RU2015151857A (en) | 2008-12-02 | 2019-01-15 | Уэйв Лайф Сайенсес Джапан, Инк. | METHOD FOR SYNTHESIS OF NUCLEIC ACIDS MODIFIED BY PHOSPHOR ATOMIC |
| SG172359A1 (en) | 2008-12-23 | 2011-07-28 | Pharmasset Inc | Nucleoside phosphoramidates |
| US8551973B2 (en) | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
| NZ593647A (en) | 2008-12-23 | 2013-08-30 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
| EP2623104A1 (en) | 2009-03-20 | 2013-08-07 | Alios Biopharma, Inc. | Substituted nucleoside and nucleotide analogs |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| TWI598358B (en) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | Nucleoside phosphoramidates |
| MX342945B (en) | 2009-07-06 | 2016-10-18 | Ontorii Inc * | Novel nucleic acid prodrugs and methods use thereof. |
| US9216979B2 (en) | 2009-10-16 | 2015-12-22 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| PH12012500734A1 (en) | 2009-10-16 | 2012-11-26 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| AU2010306646B2 (en) * | 2009-10-16 | 2016-09-01 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| SG10201406634VA (en) * | 2009-10-16 | 2014-11-27 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| JP2013527145A (en) | 2010-03-31 | 2013-06-27 | ギリード・ファーマセット・エルエルシー | Stereoselective synthesis of phosphorus-containing activators |
| PL3290428T3 (en) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tablet comprising crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate |
| CA2810928A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| WO2012040124A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| PT3042910T (en) | 2010-11-30 | 2019-04-16 | Gilead Pharmasset Llc | 2'-spiro-nucleosides for use in the therapy of hepatitis c |
| JP6317669B2 (en) | 2011-04-15 | 2018-04-25 | メリンタ セラピューティクス インコーポレイテッド | Antibacterial compounds and methods of making and using the same |
| GB201111779D0 (en) | 2011-07-08 | 2011-08-24 | Univ Cardiff | Chemical compounds |
| EP3248982A1 (en) | 2011-07-19 | 2017-11-29 | Wave Life Sciences Ltd. | Thiosulfonate reagents for the synthesis of functionalized nucleic acids |
| CA2840242C (en) | 2011-09-16 | 2019-03-26 | Gilead Sciences, Inc. | Methods for treating hcv |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| AU2012358803C1 (en) | 2011-12-22 | 2019-12-19 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| CA2860234A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
| HK1206362A1 (en) | 2012-03-21 | 2016-01-08 | Alios Biopharma, Inc. | Solid form of thiophosphoramidate nucleotide prodrug |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9012427B2 (en) | 2012-03-22 | 2015-04-21 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
| MX2014014323A (en) | 2012-05-25 | 2015-02-12 | Janssen R & D Ireland | Uracyl spirooxetane nucleosides. |
| CA2879023C (en) | 2012-07-13 | 2017-03-28 | Wave Life Sciences Japan | Asymmetric auxiliary group |
| JP6284547B2 (en) | 2012-12-21 | 2018-02-28 | アリオス バイオファーマ インク． | Substituted nucleosides, substituted nucleotides and analogs thereof |
| KR20200060782A (en) | 2013-01-31 | 2020-06-01 | 길리애드 파마셋 엘엘씨 | Combination formulation of two antiviral compounds |
| EP3650014B1 (en) | 2013-08-27 | 2021-10-06 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
| AU2014315045A1 (en) | 2013-09-09 | 2016-03-24 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| EP3039025A4 (en) | 2013-09-09 | 2017-05-31 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| EP3055319A4 (en) | 2013-10-11 | 2018-01-10 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| MX2016009290A (en) | 2014-01-16 | 2017-02-28 | Wave Life Sciences Ltd | Chiral design. |
| KR20180015114A (en) | 2015-03-11 | 2018-02-12 | 멜린타 테라퓨틱스, 인크. | Antimicrobial compounds and their preparation and use |
| EP3452479A1 (en) | 2016-05-06 | 2019-03-13 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
| CA3027097C (en) | 2016-05-10 | 2023-11-28 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of rsv |
| US11084796B2 (en) | 2016-05-10 | 2021-08-10 | Georgia State University Research Foundation, Inc. | Heterocyclic derivatives for the treatment of RSV |
| CN108586557A (en) * | 2018-01-04 | 2018-09-28 | 华东师范大学 | A kind of preparation method of Kan Geleinuo intermediates |
| CN113025651B (en) * | 2021-03-31 | 2023-03-24 | 重庆医科大学 | Novel application of drug screening cell model, triciribine and structural analogue of targeted HBV core promoter |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62255499A (en) * | 1986-04-28 | 1987-11-07 | Teijin Ltd | Fluorescent nucleoside or nucleotide |
| US20020197618A1 (en) * | 2001-01-20 | 2002-12-26 | Sampson Jeffrey R. | Synthesis and amplification of unstructured nucleic acids for rapid sequencing |
| US7371580B2 (en) * | 2001-08-24 | 2008-05-13 | Agilent Technologies, Inc. | Use of unstructured nucleic acids in assaying nucleic acid molecules |
-
2003
- 2003-03-07 AU AU2003225705A patent/AU2003225705A1/en not_active Abandoned
- 2003-03-07 WO PCT/US2003/006992 patent/WO2004080466A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004080466A1 (en) | 2004-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003225705A1 (en) | Cytidine analogs and methods of use | |
| AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
| AU2003225669A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003275311A1 (en) | Solid micro-perforators and methods of use | |
| AU2003259735A1 (en) | Small-mer compositions and methods of use | |
| AU2003291668A1 (en) | Sacrificial compositions, methods of use thereof, and methods of decomposition thereof | |
| AU2003235676A1 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| AU2003243714A1 (en) | Etoposide analogs and methods of use thereof | |
| AU2003299441A1 (en) | Nf-hev compositions and methods of use | |
| TWI339662B (en) | Arylvinylazacycloalkane compounds and methods of preparation and use thereof | |
| AU2003247351A1 (en) | Anti-acne compositions and methods of use | |
| AU2003294716A1 (en) | Detectable labeled nucleoside analogs and methods of use thereof | |
| AU2003287802A1 (en) | Palpometer and methods of use thereof | |
| AU2003242405A1 (en) | Compounds and preparaitons having antiviral effect | |
| EP1697349A4 (en) | Doxepin analogs and methods of use thereof | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| WO2005042707A9 (en) | Taspasel 1 and methods of use | |
| AU2003903251A0 (en) | Antiviral compounds and methods | |
| AU2003225642A1 (en) | Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs | |
| AU2003238034A1 (en) | Novel use of imidazotriazinones | |
| HK1094971A (en) | Doxepin analogs and methods of use thereof | |
| AU2003289640A1 (en) | Tricyclacetalactonin, Preparation and Use there of | |
| HK1092789A (en) | Deasaflabin compounds and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |